DKT WomanCare and Shanghai Dahua Pharmaceutical Reduce Price of Levoplantâ„¢ to $6.70, Increasing Affordability for FP2020 Countries, Despite Widespread Challenges Due to Covid-19

DKT WomanCare and Shanghai Dahua Pharmaceutical Reduce Price of Levoplantâ„¢ to $6.70, Increasing Affordability for FP2020 Countries, Despite Widespread Challenges Due to Covid-19 By – Jun 9, 2021 LONDON-(BUSINESS WIRE)-Despite global disruptions to family planning services due to the Covid-19 pandemic, WomanCare Global Trading CIC ( DKT WomanCare ) and Shanghai Dahua Pharmaceutical Co., Ltd. ( Dahua ) are proud to announce a price reduction of Levoplant , a two-rod contraceptive implant prequalified by the World Health Organization (WHO) for up to three years of use. Levoplant is currently registered and increasing the reproductive health autonomies of women in more…